Search research articles
Contact Us
Filters
Showing results (1-10 of 3) with videos related to
Page
of 1
Sort By:
Current Pharmaceutical Design
|
March 22, 2005
Functional characteristic of snake venom disintegrins: potential therapeutic implication
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
July 18, 2006
Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Current Pharmaceutical Design
|
November 6, 2007
KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin
Juan J Calvete, Cezary Marcinkiewicz, Libia Sanz
Page
of 1
Search research articles
Search
Showing results (1-10 of 3) with videos related to
Sort By:
Page
of 1
Current Pharmaceutical Design
|
March 22, 2005
Functional characteristic of snake venom disintegrins: potential therapeutic implication
Cezary Marcinkiewicz
Current Pharmaceutical Design
|
July 18, 2006
Cross talk between the cardiovascular and nervous systems: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effects of nerve growth factor (NGF)-implications in drug development
Philip Lazarovici, Cezary Marcinkiewicz, Peter I Lelkes
Current Pharmaceutical Design
|
November 6, 2007
KTS and RTS-disintegrins: anti-angiogenic viper venom peptides specifically targeting the alpha 1 beta 1 integrin
Juan J Calvete, Cezary Marcinkiewicz, Libia Sanz
Page
of 1